THESIS ENGLISH PRESENTATION
•Download as DOC, PDF•
1 like•154 views
This thesis examines interactions between antiretroviral HIV treatment and recreational drugs. It will present data on how interactions can occur and be prevented. For over 30 years, HIV infection has continued to spread worldwide despite medical advances. Both the number of infections and deaths from the disease are still increasing. There is also prevalent recreational drug use, and historical data links new HIV infections to psychotropic substance use. In some patients, dangerous and even fatal interactions have been observed between treatments and recreational drugs. These drugs may not only cause adherence issues but also treatment failures. More research is needed on this important phenomenon, though science has revealed and prevented some dangerous interactions.
Report
Share
Report
Share
Recommended
Risk assessment and health research in Vietnam: A first special issue of the ...
Poster prepared by Hung Nguyen-Viet and Tran Thi Tuyet Hanh for the 6th Asian Pig Veterinary Society Congress, Ho Chi Minh City, Vietnam, 23-25 September 2013.
⚡[E-PUB]DOWNLOAD Confronting Emerging Zoonoses The One Health Paradigm
This book provides readers with information on the factors underlying the emergence of infectious diseases originating in animals and spreading to people. The One Health concept recognizes the important links between human animal and environmental health and provides an important strategy in epidemic mitigation and prevention. The essential premise of the One Health concept is to break down the silos among the different health professions and promote transdisciplinary collaborations. These concepts are illustrated with indepth analyses of specific zoonotic agents and with examples of the successes and challenges associated with implementing One Health. The book also highlights some of the challenges societies face in confronting several specific zoonotic diseases. A chapter is included on comparative medicine to demonstrate the broad scope of the One Health concept. Edited by a team incl
Learning id
This document lists resources for infectious diseases, including textbooks, journals, websites, and resources for residents. It provides textbooks such as Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases and Hospital Epidemiology and Infection Control. Journals mentioned include Clinical Infectious Diseases and Lancet Infectious Diseases. Websites include Journal Watch, Medscape, and various sites for HIV/AIDS, hepatitis, and emerging diseases. Resources for residents include textbooks, MKSAP, Red Book, and reviewing major infectious disease syndromes through articles.
Apc ii -complete inpatient patient care slides
This document outlines the pharmacist's role in providing inpatient patient care. It discusses how patient care is a team effort involving doctors, nurses, pharmacists, and other support staff. It describes different treatment modalities including medical, surgical, and physical treatments. The document then lists various areas where pharmacists can contribute to patient care, such as online order review, clinical monitoring, participation in quality improvement initiatives, decentralized services, organized group efforts like committees, proactive programs, direct patient advising, documentation, discharge planning, and follow-up contact. It emphasizes that outcomes are improved when pharmacists are actively engaged in direct patient care.
Paolo boffetta
Dr. Boffetta moved to Mount Sinai School of Medicine in 2010. He is Director of the Institute for Translational Epidemiology and Associate Director for Population Sciences of The Tisch Cancer Institute. He is also the Bluhdorn Professor of International Community Medicine.
Dr. Boffetta's previous employments include Columbia University (New York, NY), the American Cancer Society (New York, NY), the American Cancer Society (New York, NY), the International Agency for Research on Cancer (Lyon, France), and the German Cancer Research Center (Heidelberg, Germany).
Food safety risk misperception: Lessons learned and way forward
Poster by Tran Thi Tuyet Hanh, Hung Nguyen-Viet, Pham Duc Phuc, Dang Xuan Sinh, Fred Unger and Delia Grace at the North-West Vietnam Research Symposium 2017, Hanoi, Vietnam, 23–24 November 2017.
Paolo boffetta
Dr. Boffetta moved to Mount Sinai School of Medicine in 2010. He is Director of the Institute for Translational Epidemiology and Associate Director for Population Sciences of The Tisch Cancer Institute. He is also the Bluhdorn Professor of International Community Medicine.
POSTER ON COVID-19
Pharmacists play several important roles in addressing the COVID-19 pandemic. Hospital pharmacists ensure adequate supplies of medicines, medical devices, masks, and protective equipment. Community pharmacists inform and educate the public on disease prevention while continuing to provide essential pharmaceutical services and medicines. Research pharmacists work to develop better drug treatments and vaccines for COVID-19. Retail pharmacists prepare and dispense prescription drugs to consumers. Academic pharmacists continue student education through online classes and increase awareness of COVID-19. Overall, pharmacists remain committed to supporting patients affected by COVID-19 and meeting other health needs during this difficult time.
Recommended
Risk assessment and health research in Vietnam: A first special issue of the ...
Poster prepared by Hung Nguyen-Viet and Tran Thi Tuyet Hanh for the 6th Asian Pig Veterinary Society Congress, Ho Chi Minh City, Vietnam, 23-25 September 2013.
⚡[E-PUB]DOWNLOAD Confronting Emerging Zoonoses The One Health Paradigm
This book provides readers with information on the factors underlying the emergence of infectious diseases originating in animals and spreading to people. The One Health concept recognizes the important links between human animal and environmental health and provides an important strategy in epidemic mitigation and prevention. The essential premise of the One Health concept is to break down the silos among the different health professions and promote transdisciplinary collaborations. These concepts are illustrated with indepth analyses of specific zoonotic agents and with examples of the successes and challenges associated with implementing One Health. The book also highlights some of the challenges societies face in confronting several specific zoonotic diseases. A chapter is included on comparative medicine to demonstrate the broad scope of the One Health concept. Edited by a team incl
Learning id
This document lists resources for infectious diseases, including textbooks, journals, websites, and resources for residents. It provides textbooks such as Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases and Hospital Epidemiology and Infection Control. Journals mentioned include Clinical Infectious Diseases and Lancet Infectious Diseases. Websites include Journal Watch, Medscape, and various sites for HIV/AIDS, hepatitis, and emerging diseases. Resources for residents include textbooks, MKSAP, Red Book, and reviewing major infectious disease syndromes through articles.
Apc ii -complete inpatient patient care slides
This document outlines the pharmacist's role in providing inpatient patient care. It discusses how patient care is a team effort involving doctors, nurses, pharmacists, and other support staff. It describes different treatment modalities including medical, surgical, and physical treatments. The document then lists various areas where pharmacists can contribute to patient care, such as online order review, clinical monitoring, participation in quality improvement initiatives, decentralized services, organized group efforts like committees, proactive programs, direct patient advising, documentation, discharge planning, and follow-up contact. It emphasizes that outcomes are improved when pharmacists are actively engaged in direct patient care.
Paolo boffetta
Dr. Boffetta moved to Mount Sinai School of Medicine in 2010. He is Director of the Institute for Translational Epidemiology and Associate Director for Population Sciences of The Tisch Cancer Institute. He is also the Bluhdorn Professor of International Community Medicine.
Dr. Boffetta's previous employments include Columbia University (New York, NY), the American Cancer Society (New York, NY), the American Cancer Society (New York, NY), the International Agency for Research on Cancer (Lyon, France), and the German Cancer Research Center (Heidelberg, Germany).
Food safety risk misperception: Lessons learned and way forward
Poster by Tran Thi Tuyet Hanh, Hung Nguyen-Viet, Pham Duc Phuc, Dang Xuan Sinh, Fred Unger and Delia Grace at the North-West Vietnam Research Symposium 2017, Hanoi, Vietnam, 23–24 November 2017.
Paolo boffetta
Dr. Boffetta moved to Mount Sinai School of Medicine in 2010. He is Director of the Institute for Translational Epidemiology and Associate Director for Population Sciences of The Tisch Cancer Institute. He is also the Bluhdorn Professor of International Community Medicine.
POSTER ON COVID-19
Pharmacists play several important roles in addressing the COVID-19 pandemic. Hospital pharmacists ensure adequate supplies of medicines, medical devices, masks, and protective equipment. Community pharmacists inform and educate the public on disease prevention while continuing to provide essential pharmaceutical services and medicines. Research pharmacists work to develop better drug treatments and vaccines for COVID-19. Retail pharmacists prepare and dispense prescription drugs to consumers. Academic pharmacists continue student education through online classes and increase awareness of COVID-19. Overall, pharmacists remain committed to supporting patients affected by COVID-19 and meeting other health needs during this difficult time.
Patient Information System
January 2012 – May 2012
Collaborated a database to input customer’s information
o Database would provide an easy method to locate current customers based on demographic and geographic variables
Clinic Management System
The Clinic Management System (CMS) is a complete web-based hospital management solution with 7 modules: registration, accounts, consultations, investigations, reports, edit, and administrator. It allows for registration of patients, doctor fee and test fee screens, prescription reports, bio-chemical, hematological, serology, and other medical test screens. The system was created using Visual Studio 2013, SQL Server 2008, and Telerik controls with C#, HTML, and CSS.
Neerogi - A Patient Information Management System (PIMS)
This document discusses Neerogi, an open source patient information management system (PIMS) developed in Sri Lanka. It began as an initiative by Dr. Thusith Gunawardane to be used at Base Hospital Wathupitiwala. A PIMS like Neerogi provides advantages like quick access to patient information, improved data collection, and increased staff productivity. It also allows aggregated patient data analysis that can be useful for national healthcare planning and monitoring disease trends. The document demonstrates Neerogi and explains its functionality includes managing patient medical records, conditions, investigations, and treatment plans.
clinic database and software management system
This document describes a study conducted on developing an automated patient record management system for St. Francis Hospital Nsambya. It outlines the background and problems with the current manual system, including duplication of data, inconsistencies, and difficulty analyzing patient medical histories. The objectives are to computerize patient, staff, and drug supplier records to address issues with the manual system. The study involved analyzing the existing system and user requirements to design a new electronic system using databases, PHP, and MySQL. The system was implemented and tested to automate record keeping and improve management of patient information at the hospital.
PROJECT-HOSPITAL MANAGEMENT SYSTEM CHAP. 1 TO 4
This document provides background information on the proposed Nyamache Management System project. It summarizes the current manual patient record keeping system at Nyamache Hospital, which involves paper-based registration, billing, and record retrieval. This is inefficient and error-prone. The proposed electronic system aims to improve accuracy, efficiency and information retrieval. It will involve modules for registration, billing, stock management and administration. The document outlines the project objectives, budget, and methodology using a system development lifecycle approach involving planning, analysis, design, testing and documentation.
Hospital management system project
This document provides an overview and requirements for developing a Hospital Management System. It describes collecting both primary and secondary data. Key objectives of the system are to computerize patient and hospital details, schedule appointments and services, update medical store inventory, handle test reports, and keep patient information up-to-date. The system will have modules for login, patients, doctors, billing, and generating reports. It will use a relational database with tables for patient, doctor, room, and bill details.
Guidance for infectious disease
The document provides guidance on preventing and controlling infectious diseases among people who inject drugs. It recommends 7 key interventions: 1) providing clean injection equipment, 2) vaccination, 3) drug dependence treatment such as opioid substitution treatment, 4) voluntary testing and linking to treatment, 5) treatment for infectious diseases, 6) health promotion, and 7) targeted delivery of services. The interventions should be combined and delivered according to user needs to maximize effectiveness in reducing infections.
111012 guidance infectious_diseases_idu_brief.pdf
The document provides guidance on preventing and controlling infectious diseases among people who inject drugs. It recommends 7 key interventions: 1) providing clean injection equipment, 2) vaccination, 3) drug dependence treatment such as opioid substitution treatment, 4) voluntary testing and linking to treatment, 5) treatment for infectious diseases, 6) health promotion, and 7) targeted delivery of services. The interventions should be combined and delivered according to user needs to maximize effectiveness and prevention synergy.
Anti microbial program nepal
This document presents Nepal's National Antimicrobial Resistance Containment Action Plan for 2016. It outlines the growing threat of antimicrobial resistance in Nepal due to overuse and misuse of antibiotics. Laboratory surveillance data from 20 participating labs shows increasing resistance to common antibiotics used to treat Salmonella, Shigella, pneumococci and other bacteria. The plan establishes 5 strategic objectives to address antimicrobial resistance through improved surveillance, stewardship, infection prevention, research and regional/international cooperation. It recognizes that containing antimicrobial resistance requires a coordinated one health approach across government agencies, private sectors and other stakeholders.
Running head JUBLIA1JUBLIA2JubliaChambe.docx
Running head: JUBLIA 1
JUBLIA 2
Jublia
Chamberlain College of Nursing
NR-293, Pharmacology
Linda Le
Professor Ward
February 14, 2019
Jublia
This brochure has been designed to inform the people about the use of Efinaconazole for the treatment of onychomycosis. Onychomycosis is known as a fungal infection of the nail. This is targeted to educate the people on the treatment and use of Jublia as a toenail treatment. The brochure explains a small intro of necessary information regarding medicine like drug class, mechanism of action, and treat guide. The side effects and interactions are also explained. This is designed to provide awareness to layman regarding toenail infections.
References
Elewski, B. E., Rich, P., Pollak, R., Pariser, D. M., Watanabe, S., Senda, H., ... & Oli n, J. T. (2013).
Efinaconazole 10% solution in the treatment of toenail onychomycosis: two phase III
multicenter, randomized, double-blind studies. Journal of the American Academy of
Dermatology, 68(4), 600-608.
Tschen, E. H., Bucko, A. D., Oizumi, N., Kawabata, H., Olin, J. T., & Pillai, R. (2013).
Efinaconazole solution in the treatment of toenail onychomycosis: a phase 2, multicenter,
randomized, double-blind study. J Drugs Dermatol, 12(2), 186-92.
RentSilverSpring.xlsx
DATASize (Square feet) Rent ($)52411106161175666119083014104501210550122578014808151490107014956101680835181066016255901469675139574411508201140912122062814346451519840110580011308041250950144980011687871224960139175011456901093840135385015309651650106017406651235775155096015458271583655157553513106251195749120063411856411444860138574012755931050880165089513406921560
Starbucks.xlsx
DATATearViscosityPressurePlate Gap0.00350.00180.000.000.00350.00170.000.000.45319.00186.001.800.85380.00174.001.800.35350.00180.000.000.30300.00180.000.000.70400.00180.000.001.90350.00190.000.000.25350.00180.000.000.10319.00186.00-1.800.15380.00186.00-1.803.90350.00180.003.000.00380.00174.00-1.800.55350.00180.000.000.00350.00180.00-3.000.05319.00174.00-1.800.40319.00174.001.804.30380.00186.001.800.00350.00180.000.00
VinhoVerde.xlsx
DATAFixed AcidityVolatile AcidityCitric AcidResidual SugarChloridesFree Sulfur DioxideTotal Sulfur DioxideDensitypHSulphatesAlcoholQuality11.50.30.620.06712270.99813.110.9710.167.70.7150.012.10.06431430.993713.410.5711.8610.40.5750.612.60.076112413.160.69959.20.630.212.70.09729650.99883.280.589.657.90.350.463.60.07815370.99733.350.8612.888.90.7450.182.50.07715480.997393.20.479.767.60.510.242.40.0918380.9983.470.669.6610.80.50.462.50.0735271.00013.050.649.556.40.470.42.40.0718190.99633.560.7310.669.90.630.242.40.0776330.99743.090.579.456.90.68502.50.10522370.99663.460.5710.667.30.450.365.90.07412870.99783.330.8310.556.80.810.0520.076140.995623.510.6610.867.50.510.021.70.08413310.995383.360.5410.5610.40.340.583.70.1746160.9973.190.711.367.10.460.142.80.07615370.996243.360.4910.759.10.50.31.90.0658170.997743.320.7110.567.30.690.322.20.069351040.996323..
How to tackle antibiotic resistence
Antimicrobial resistance is caused by overuse and misuse of antibiotics and other antimicrobial drugs in humans, animals, and agriculture. This threatens modern medicine by rendering many lifesaving drugs ineffective. A global action plan was adopted with five objectives: improving awareness, strengthening surveillance and research, reducing infections through hygiene, optimizing antimicrobial use, and increasing investment in new treatments. Coordinated action across all sectors of society is needed to tackle this growing crisis.
POISON CONTROL CENTRE
A poison control center provides free, expert medical advice and treatment for poison exposures via telephone. They answer questions about potential poisons and provide treatment advice for products, medicines, pesticides, plants, bites and more. Over 72% of poison exposure cases are managed by phone alone. Poison control centers greatly reduce emergency visits and their costs. Free help from poison control centers is available 24/7 in many countries and languages.
Afternoon Session A Consultation on Patented Medicine Prices Review Board & B...
Afternoon Session A Consultation on Patented Medicine Prices Review Board & B...Canadian Organization for Rare Disorders
This document provides a summary of a joint research report from the International Alliance of Patients’ Organisations (IAPO) and the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) on biologic medicines. It discusses how biologics have benefited over 350 million patients worldwide by treating illnesses like cancer, heart disease, and arthritis. The report aims to inform patients, health organizations, and policymakers on ensuring optimal, safe, and appropriate access to biologics globally. It explains what biologics are, how they should be regulated and monitored, and how patients can make informed decisions about their use. The document was authored by the Institute for Optimizing Health Outcomes, commissioned by IAPO andPharmacovigilance
Pharmacovigilance involves monitoring the safety of drugs at all stages, from development through post-marketing. It aims to detect, understand, and prevent adverse drug reactions through activities like adverse event reporting, drug monitoring, and studying medication errors and drug-related deaths. Pharmacovigilance is important for protecting public health as patterns of drug use change over time with globalization and advances in technology and medicine.
final Scope Of Public Health Microbiology.pptx
Public health microbiology comprises the disciplines of microbiology and public health. It refers to the study of microorganisms like viruses, fungi, parasites and bacteria that impact human health. A public health microbiologist works in public health laboratories and coordinates with various professionals like epidemiologists, veterinarians and environmentalists. Their key roles are to conduct surveillance of infectious diseases, investigate outbreaks, develop diagnostic tests and provide evidence to inform public health measures for disease control. Such measures include improving global surveillance, reducing inappropriate drug use, enhancing vector and zoonotic control, promoting health education and developing predictive models.
Clinical impact of pharmacist presence in icu medical team on mortality rate ...
Clinical impact of pharmacist presence in icu medical team on mortality rate ...M. Luisetto Pharm.D.Spec. Pharmacology
This article examines the role of clinical pharmacists in intensive care unit (ICU) medical teams and their impact on reducing mortality rates. It discusses how including pharmacists in daily ICU activities can optimize drug therapy, improve patient safety, and lower costs from medical errors and extended hospital stays. The article reviews literature showing that when pharmacists are involved in clinical decision making on medical teams, various clinical outcomes generally improve and mortality rates noticeably decrease.Nili luisetto-nili-nasser-mashori-nili-2016-1-15-33 clinical impact of pharma...
Nili luisetto-nili-nasser-mashori-nili-2016-1-15-33 clinical impact of pharma...on line resource to link researchers works to investors
This article examines the role of clinical pharmacists in intensive care unit (ICU) medical teams and their impact on reducing mortality rates. It discusses how including pharmacists in daily ICU activities can optimize drug therapy, improve patient safety, and lower costs from medical errors and extended hospital stays. Studies show that when pharmacists are integrated into the medical team, there are generally improvements in clinical outcomes and reduced mortality rates compared to teams without pharmacists. The pharmacists' role in advising on appropriate medication use helps prevent health risks and unnecessary expenses.Steps and impact of pharmaceutical care and clinical pharmacy development on ...
Steps and impact of pharmaceutical care and clinical pharmacy development on ...M. Luisetto Pharm.D.Spec. Pharmacology
The document summarizes the historical development of clinical pharmacy and pharmaceutical care from 1928 to 2016. It outlines key steps such as pharmacists beginning to participate in patient rounds in 1928. It also reviews studies showing the positive impact of clinical pharmacists on patient outcomes when included as part of the medical team. This includes reduced mortality, readmission rates, and healthcare costs. The conclusion is that incorporating clinical pharmacy expertise into medical care through a flexible team-based approach is essential for improving clinical outcomes, especially with new complex drug formulations.Steps and impact of pharmaceutical care and clinical pharmacy development on ...
Steps and impact of pharmaceutical care and clinical pharmacy development on ...on line resource to link researchers works to investors
1) The introduction of pharmaceutical care and clinical pharmacy practices in the 1920s positively impacted patient outcomes.
2) Over time from the 1920s-2016, clinical pharmacy evolved as its own discipline and pharmacists increasingly participated in direct patient care as part of medical teams.
3) Studies found the involvement of clinical pharmacists on medical teams generally had favorable effects on various outcomes across different healthcare settings and disease states.Síndome de L-N.pdf
Botulinum toxin injections were found to be a useful and safe treatment for reducing self-biting behavior in six patients with Lesch-Nyhan disease. Patients received an average of 20 botulinum toxin injections over 1.5 to 7.1 years, with injections targeting the masticatory muscles, biceps brachii, and other muscles. Of the 119 total injections, 113 (95%) were partially or completely effective in reducing self-biting. Only 3 injections (2.5%) produced adverse effects such as difficulty swallowing or general weakness. Botulinum toxin injections provided an effective treatment option for managing self-injurious behavior in patients with Lesch-Nyhan disease.
Antimicrobial-stewardship.ppt
The WHO has identified antibiotic resistance as one of the greatest threats to human health. While antibiotic usage occurs most in the community, there are currently no coordinated antimicrobial stewardship programs between hospitals and the community. Educational programs aim to increase awareness among healthcare professionals and the public about appropriate antibiotic use and resistance, though challenges remain in diagnosing infections and balancing patient expectations. Coordinated efforts are needed across human and animal health as well as agriculture to preserve antibiotic effectiveness.
More Related Content
Viewers also liked
Patient Information System
January 2012 – May 2012
Collaborated a database to input customer’s information
o Database would provide an easy method to locate current customers based on demographic and geographic variables
Clinic Management System
The Clinic Management System (CMS) is a complete web-based hospital management solution with 7 modules: registration, accounts, consultations, investigations, reports, edit, and administrator. It allows for registration of patients, doctor fee and test fee screens, prescription reports, bio-chemical, hematological, serology, and other medical test screens. The system was created using Visual Studio 2013, SQL Server 2008, and Telerik controls with C#, HTML, and CSS.
Neerogi - A Patient Information Management System (PIMS)
This document discusses Neerogi, an open source patient information management system (PIMS) developed in Sri Lanka. It began as an initiative by Dr. Thusith Gunawardane to be used at Base Hospital Wathupitiwala. A PIMS like Neerogi provides advantages like quick access to patient information, improved data collection, and increased staff productivity. It also allows aggregated patient data analysis that can be useful for national healthcare planning and monitoring disease trends. The document demonstrates Neerogi and explains its functionality includes managing patient medical records, conditions, investigations, and treatment plans.
clinic database and software management system
This document describes a study conducted on developing an automated patient record management system for St. Francis Hospital Nsambya. It outlines the background and problems with the current manual system, including duplication of data, inconsistencies, and difficulty analyzing patient medical histories. The objectives are to computerize patient, staff, and drug supplier records to address issues with the manual system. The study involved analyzing the existing system and user requirements to design a new electronic system using databases, PHP, and MySQL. The system was implemented and tested to automate record keeping and improve management of patient information at the hospital.
PROJECT-HOSPITAL MANAGEMENT SYSTEM CHAP. 1 TO 4
This document provides background information on the proposed Nyamache Management System project. It summarizes the current manual patient record keeping system at Nyamache Hospital, which involves paper-based registration, billing, and record retrieval. This is inefficient and error-prone. The proposed electronic system aims to improve accuracy, efficiency and information retrieval. It will involve modules for registration, billing, stock management and administration. The document outlines the project objectives, budget, and methodology using a system development lifecycle approach involving planning, analysis, design, testing and documentation.
Hospital management system project
This document provides an overview and requirements for developing a Hospital Management System. It describes collecting both primary and secondary data. Key objectives of the system are to computerize patient and hospital details, schedule appointments and services, update medical store inventory, handle test reports, and keep patient information up-to-date. The system will have modules for login, patients, doctors, billing, and generating reports. It will use a relational database with tables for patient, doctor, room, and bill details.
Viewers also liked (6)
Neerogi - A Patient Information Management System (PIMS)
Neerogi - A Patient Information Management System (PIMS)
Similar to THESIS ENGLISH PRESENTATION
Guidance for infectious disease
The document provides guidance on preventing and controlling infectious diseases among people who inject drugs. It recommends 7 key interventions: 1) providing clean injection equipment, 2) vaccination, 3) drug dependence treatment such as opioid substitution treatment, 4) voluntary testing and linking to treatment, 5) treatment for infectious diseases, 6) health promotion, and 7) targeted delivery of services. The interventions should be combined and delivered according to user needs to maximize effectiveness in reducing infections.
111012 guidance infectious_diseases_idu_brief.pdf
The document provides guidance on preventing and controlling infectious diseases among people who inject drugs. It recommends 7 key interventions: 1) providing clean injection equipment, 2) vaccination, 3) drug dependence treatment such as opioid substitution treatment, 4) voluntary testing and linking to treatment, 5) treatment for infectious diseases, 6) health promotion, and 7) targeted delivery of services. The interventions should be combined and delivered according to user needs to maximize effectiveness and prevention synergy.
Anti microbial program nepal
This document presents Nepal's National Antimicrobial Resistance Containment Action Plan for 2016. It outlines the growing threat of antimicrobial resistance in Nepal due to overuse and misuse of antibiotics. Laboratory surveillance data from 20 participating labs shows increasing resistance to common antibiotics used to treat Salmonella, Shigella, pneumococci and other bacteria. The plan establishes 5 strategic objectives to address antimicrobial resistance through improved surveillance, stewardship, infection prevention, research and regional/international cooperation. It recognizes that containing antimicrobial resistance requires a coordinated one health approach across government agencies, private sectors and other stakeholders.
Running head JUBLIA1JUBLIA2JubliaChambe.docx
Running head: JUBLIA 1
JUBLIA 2
Jublia
Chamberlain College of Nursing
NR-293, Pharmacology
Linda Le
Professor Ward
February 14, 2019
Jublia
This brochure has been designed to inform the people about the use of Efinaconazole for the treatment of onychomycosis. Onychomycosis is known as a fungal infection of the nail. This is targeted to educate the people on the treatment and use of Jublia as a toenail treatment. The brochure explains a small intro of necessary information regarding medicine like drug class, mechanism of action, and treat guide. The side effects and interactions are also explained. This is designed to provide awareness to layman regarding toenail infections.
References
Elewski, B. E., Rich, P., Pollak, R., Pariser, D. M., Watanabe, S., Senda, H., ... & Oli n, J. T. (2013).
Efinaconazole 10% solution in the treatment of toenail onychomycosis: two phase III
multicenter, randomized, double-blind studies. Journal of the American Academy of
Dermatology, 68(4), 600-608.
Tschen, E. H., Bucko, A. D., Oizumi, N., Kawabata, H., Olin, J. T., & Pillai, R. (2013).
Efinaconazole solution in the treatment of toenail onychomycosis: a phase 2, multicenter,
randomized, double-blind study. J Drugs Dermatol, 12(2), 186-92.
RentSilverSpring.xlsx
DATASize (Square feet) Rent ($)52411106161175666119083014104501210550122578014808151490107014956101680835181066016255901469675139574411508201140912122062814346451519840110580011308041250950144980011687871224960139175011456901093840135385015309651650106017406651235775155096015458271583655157553513106251195749120063411856411444860138574012755931050880165089513406921560
Starbucks.xlsx
DATATearViscosityPressurePlate Gap0.00350.00180.000.000.00350.00170.000.000.45319.00186.001.800.85380.00174.001.800.35350.00180.000.000.30300.00180.000.000.70400.00180.000.001.90350.00190.000.000.25350.00180.000.000.10319.00186.00-1.800.15380.00186.00-1.803.90350.00180.003.000.00380.00174.00-1.800.55350.00180.000.000.00350.00180.00-3.000.05319.00174.00-1.800.40319.00174.001.804.30380.00186.001.800.00350.00180.000.00
VinhoVerde.xlsx
DATAFixed AcidityVolatile AcidityCitric AcidResidual SugarChloridesFree Sulfur DioxideTotal Sulfur DioxideDensitypHSulphatesAlcoholQuality11.50.30.620.06712270.99813.110.9710.167.70.7150.012.10.06431430.993713.410.5711.8610.40.5750.612.60.076112413.160.69959.20.630.212.70.09729650.99883.280.589.657.90.350.463.60.07815370.99733.350.8612.888.90.7450.182.50.07715480.997393.20.479.767.60.510.242.40.0918380.9983.470.669.6610.80.50.462.50.0735271.00013.050.649.556.40.470.42.40.0718190.99633.560.7310.669.90.630.242.40.0776330.99743.090.579.456.90.68502.50.10522370.99663.460.5710.667.30.450.365.90.07412870.99783.330.8310.556.80.810.0520.076140.995623.510.6610.867.50.510.021.70.08413310.995383.360.5410.5610.40.340.583.70.1746160.9973.190.711.367.10.460.142.80.07615370.996243.360.4910.759.10.50.31.90.0658170.997743.320.7110.567.30.690.322.20.069351040.996323..
How to tackle antibiotic resistence
Antimicrobial resistance is caused by overuse and misuse of antibiotics and other antimicrobial drugs in humans, animals, and agriculture. This threatens modern medicine by rendering many lifesaving drugs ineffective. A global action plan was adopted with five objectives: improving awareness, strengthening surveillance and research, reducing infections through hygiene, optimizing antimicrobial use, and increasing investment in new treatments. Coordinated action across all sectors of society is needed to tackle this growing crisis.
POISON CONTROL CENTRE
A poison control center provides free, expert medical advice and treatment for poison exposures via telephone. They answer questions about potential poisons and provide treatment advice for products, medicines, pesticides, plants, bites and more. Over 72% of poison exposure cases are managed by phone alone. Poison control centers greatly reduce emergency visits and their costs. Free help from poison control centers is available 24/7 in many countries and languages.
Afternoon Session A Consultation on Patented Medicine Prices Review Board & B...
Afternoon Session A Consultation on Patented Medicine Prices Review Board & B...Canadian Organization for Rare Disorders
This document provides a summary of a joint research report from the International Alliance of Patients’ Organisations (IAPO) and the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) on biologic medicines. It discusses how biologics have benefited over 350 million patients worldwide by treating illnesses like cancer, heart disease, and arthritis. The report aims to inform patients, health organizations, and policymakers on ensuring optimal, safe, and appropriate access to biologics globally. It explains what biologics are, how they should be regulated and monitored, and how patients can make informed decisions about their use. The document was authored by the Institute for Optimizing Health Outcomes, commissioned by IAPO andPharmacovigilance
Pharmacovigilance involves monitoring the safety of drugs at all stages, from development through post-marketing. It aims to detect, understand, and prevent adverse drug reactions through activities like adverse event reporting, drug monitoring, and studying medication errors and drug-related deaths. Pharmacovigilance is important for protecting public health as patterns of drug use change over time with globalization and advances in technology and medicine.
final Scope Of Public Health Microbiology.pptx
Public health microbiology comprises the disciplines of microbiology and public health. It refers to the study of microorganisms like viruses, fungi, parasites and bacteria that impact human health. A public health microbiologist works in public health laboratories and coordinates with various professionals like epidemiologists, veterinarians and environmentalists. Their key roles are to conduct surveillance of infectious diseases, investigate outbreaks, develop diagnostic tests and provide evidence to inform public health measures for disease control. Such measures include improving global surveillance, reducing inappropriate drug use, enhancing vector and zoonotic control, promoting health education and developing predictive models.
Clinical impact of pharmacist presence in icu medical team on mortality rate ...
Clinical impact of pharmacist presence in icu medical team on mortality rate ...M. Luisetto Pharm.D.Spec. Pharmacology
This article examines the role of clinical pharmacists in intensive care unit (ICU) medical teams and their impact on reducing mortality rates. It discusses how including pharmacists in daily ICU activities can optimize drug therapy, improve patient safety, and lower costs from medical errors and extended hospital stays. The article reviews literature showing that when pharmacists are involved in clinical decision making on medical teams, various clinical outcomes generally improve and mortality rates noticeably decrease.Nili luisetto-nili-nasser-mashori-nili-2016-1-15-33 clinical impact of pharma...
Nili luisetto-nili-nasser-mashori-nili-2016-1-15-33 clinical impact of pharma...on line resource to link researchers works to investors
This article examines the role of clinical pharmacists in intensive care unit (ICU) medical teams and their impact on reducing mortality rates. It discusses how including pharmacists in daily ICU activities can optimize drug therapy, improve patient safety, and lower costs from medical errors and extended hospital stays. Studies show that when pharmacists are integrated into the medical team, there are generally improvements in clinical outcomes and reduced mortality rates compared to teams without pharmacists. The pharmacists' role in advising on appropriate medication use helps prevent health risks and unnecessary expenses.Steps and impact of pharmaceutical care and clinical pharmacy development on ...
Steps and impact of pharmaceutical care and clinical pharmacy development on ...M. Luisetto Pharm.D.Spec. Pharmacology
The document summarizes the historical development of clinical pharmacy and pharmaceutical care from 1928 to 2016. It outlines key steps such as pharmacists beginning to participate in patient rounds in 1928. It also reviews studies showing the positive impact of clinical pharmacists on patient outcomes when included as part of the medical team. This includes reduced mortality, readmission rates, and healthcare costs. The conclusion is that incorporating clinical pharmacy expertise into medical care through a flexible team-based approach is essential for improving clinical outcomes, especially with new complex drug formulations.Steps and impact of pharmaceutical care and clinical pharmacy development on ...
Steps and impact of pharmaceutical care and clinical pharmacy development on ...on line resource to link researchers works to investors
1) The introduction of pharmaceutical care and clinical pharmacy practices in the 1920s positively impacted patient outcomes.
2) Over time from the 1920s-2016, clinical pharmacy evolved as its own discipline and pharmacists increasingly participated in direct patient care as part of medical teams.
3) Studies found the involvement of clinical pharmacists on medical teams generally had favorable effects on various outcomes across different healthcare settings and disease states.Síndome de L-N.pdf
Botulinum toxin injections were found to be a useful and safe treatment for reducing self-biting behavior in six patients with Lesch-Nyhan disease. Patients received an average of 20 botulinum toxin injections over 1.5 to 7.1 years, with injections targeting the masticatory muscles, biceps brachii, and other muscles. Of the 119 total injections, 113 (95%) were partially or completely effective in reducing self-biting. Only 3 injections (2.5%) produced adverse effects such as difficulty swallowing or general weakness. Botulinum toxin injections provided an effective treatment option for managing self-injurious behavior in patients with Lesch-Nyhan disease.
Antimicrobial-stewardship.ppt
The WHO has identified antibiotic resistance as one of the greatest threats to human health. While antibiotic usage occurs most in the community, there are currently no coordinated antimicrobial stewardship programs between hospitals and the community. Educational programs aim to increase awareness among healthcare professionals and the public about appropriate antibiotic use and resistance, though challenges remain in diagnosing infections and balancing patient expectations. Coordinated efforts are needed across human and animal health as well as agriculture to preserve antibiotic effectiveness.
Research article Pharmacists cognitive service and pharmaceutical care today ...
Research article Pharmacists cognitive service and pharmaceutical care today ...M. Luisetto Pharm.D.Spec. Pharmacology
The document discusses the changing role of pharmacists and the benefits of integrating pharmacists into medical teams. It presents several studies that show pharmacists improving clinical outcomes when involved in patient care. The rationale is that pharmacists can help physicians optimize drug therapy and patient safety by providing expertise in areas like monitoring treatments, detecting interactions and adverse reactions, and managing costs. The conclusion is that applying pharmaceutical care principles can both improve health outcomes and reduce healthcare costs.Pharmacovigilance
Pharmacovigilance (PV) is defined as the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problem. WHO established its Programme for International Drug Monitoring in response to the thalidomide disaster detected in 1961. Together with the WHO Collaborating Centre for International Drug Monitoring, Uppsala, WHO promotes PV at the country level. At the end of 2010, 134 countries were part of the WHO PV Programme. The aims of PV are to enhance patient care and patient safety in relation to the use of medicines; and to support public health programmes by providing reliable, balanced information for the effective assessment of the risk-benefit profile of medicines.
Essential drug for B. Sc. Nursing 1st year students of BPKIHS
Essential drug for B. Sc. Nursing 1st year students of BPKIHSBP KOIRALA INSTITUTE OF HELATH SCIENCS,, NEPAL
This document provides guidelines for physicians, pharmacists, nurses and medical auxiliaries on essential drugs. It includes an introduction by the Director of the World Health Organization's Essential Drugs and Other Medicines department, as well as sections on the editorial committee, contributors, preface, foreword, and use of the guide.KNOWLEDGE AND PRACTICES AMONG SURGEONS REGARDING CROSS INFECTION CONTROL PROC...
The study revealed good knowledge of infection control procedures but there were problems in practices of
sterilization. Most of them did not separate the needle from the syringe prior to disposal therefore needle
prick injuries were common. So more intensive and regular training programs to surgeons must be included
in the plans of quality control in all hospital and regular inspection from the ministry of health guarantees
good infection control practices
Similar to THESIS ENGLISH PRESENTATION (20)
Afternoon Session A Consultation on Patented Medicine Prices Review Board & B...
Afternoon Session A Consultation on Patented Medicine Prices Review Board & B...
Clinical impact of pharmacist presence in icu medical team on mortality rate ...
Clinical impact of pharmacist presence in icu medical team on mortality rate ...
Nili luisetto-nili-nasser-mashori-nili-2016-1-15-33 clinical impact of pharma...
Nili luisetto-nili-nasser-mashori-nili-2016-1-15-33 clinical impact of pharma...
Steps and impact of pharmaceutical care and clinical pharmacy development on ...
Steps and impact of pharmaceutical care and clinical pharmacy development on ...
Steps and impact of pharmaceutical care and clinical pharmacy development on ...
Steps and impact of pharmaceutical care and clinical pharmacy development on ...
Research article Pharmacists cognitive service and pharmaceutical care today ...
Research article Pharmacists cognitive service and pharmaceutical care today ...
Essential drug for B. Sc. Nursing 1st year students of BPKIHS
Essential drug for B. Sc. Nursing 1st year students of BPKIHS
KNOWLEDGE AND PRACTICES AMONG SURGEONS REGARDING CROSS INFECTION CONTROL PROC...
KNOWLEDGE AND PRACTICES AMONG SURGEONS REGARDING CROSS INFECTION CONTROL PROC...
THESIS ENGLISH PRESENTATION
- 1. UNIVERSITY OF NANTES UFR PHARMACEUTICAL AND BIOLOGICAL SCIENCES ____________________________________________________________________________________________________ YEAR 2014 N° THESIS For the STATE DIPLOMA OF DOCTOR OF PHARMACY by Olivier ANGIBAUD ----------------------------------------- Presented and supported publicly November 17th, 2014 Interactions between antiretroviral treatment and recreational drugs Président : Pr Yves-François POUCHUS, Professor of Botany and Mycology Jury members: Pr Alain PINEAU, Professor de Toxicology, Hygiene et First Aid Mr Igor DOMINGUEZ, Doctor of pharmacy, Pharmacy Owner
- 2. UNIVERSITY OF NANTES Year of the presentation 2014 ___________________________________________________________________________ Full Name : Olivier Isaac Marc Angibaud Thesis title : Interactions between antiretroviral treatment and recreational drugs. ___________________________________________________________________________ Abstract : For over thirty years, HIV infection has continued to prevail in all regions of the world. Despite medical advances, we are still not able to eradicate the phenomenon. The number of infections and deaths from the disease continues to increase. There is also a prevalent use of illegal drugs. Historical data shows the existence of a link between new infections of the virus and the use of psychotropic substances. In some patients, dangerous interactions between treatments and recreational drugs were observed, including fatalities. These drugs may be responsible not only for adherence issues but also for HIV treatment failures. Not enough research on the phenomenon exists, despite its importance. Science, including toxicology, has revealed and prevented some of the dangerous interactions. In this thesis, data will be presented to show how the interactions may occur and how they can be prevented. KEY WORDS HIV, RECREATIONAL DRUGS, HIV THERAPIES, ANTIRETROVIRAL DRUGS, INTERACTIONS, TOXICOLOGY ___________________________________________________________________________ JURY PRESIDENT : Pr Yves-François POUCHUS, Professor of botanic and mycology Pharmacy school of Nantes ASSESSORS : Pr Alain PINEAU, Professor of toxicology, Hygiena et secourism Pharmacy school of Nantes Mr Igor DOMINGUEZ, Doctor of pharmacy, Pharmacy owner 26 rue du temple, 75004 Paris ___________________________________________________________________________ Author’s adress : Olivier ANGIBAUD 383 Stockton ave, San Jose, CA 95126